2013•Chin J Colorec Dis (Electronic Edition)Requires access

The study of combining AC133 antigen and E-cadherin in the identifying metastatic colorectal cancer stem cells

Hangxiang Du, Zhili Yang, Yi Yang, Nengquan Sheng

Open publisher page 0 citations

Abstract

Objective To isolate colorectal cancer stem cells from human fresh carcinoma samples obtained at surgical operation and to study their biological characteristics.Then to provide foundation for the follow-up experiments. Methods Colorectal cancer tissues obtained from surgically resected specimens of colorectal cancer patients were fully chopped, trypsinized, and filtered to prepare single cell suspensions.The cells were cultured in serum-free DMEM/F12 medium, with LIF, EGF, bFGF and 2% fetal bovine serum weekly.The stem cell-markers AC133 and EpCAM on the isolated cells were detected by using flow cytometry.The tumorigenic potent of the isolated cells was evaluated via the transplantation into Balb/C nude mice.All the variables were tested with T-test.P<0.05 was considered to be statistically significant. Results AC133+ EpCAM+ colorectal cancer stem cells were isolated and purified from the human primary colorectal carcinoma.The percentage of AC133+ EpCAM+ colorectal cancer stem cells in primary colorectal cancer was 1.5%~35%(mean 4.8%). There were colon cancer stem cells in colon cancer by limited dilution assay.The percentage was 2.18±0.15%.The suspension spheres were generated by the isolated AC133+ EpCAM+ Co-CSCs in serum-free medium.Their differentiation were induced in medium containing 10% FBS.AC133+ EpCAM+ CCSCs were implanted into Balb/C nude mice, and observed stronger capacity of tumor initiation.The percentage of AC133+ EpCAM+ cells in xenografts was 4.9%~40.2%(mean 17.2%). Human CRC xenografts established in Balb/C nude mice grew as differentiated carcinomas, which formed gland-like structures and scored positive for expression of colon-specific differentiation markers, such as cytokeratin-20(CK20), and neutral epithelial mucins. Conclusions There are colon cancer stem cells in human colorectal carcinoma.These cells are characterized by AC133+ EpCAM+ surface marker, which possess apparent feature of stem cells and stronger capacity of initiating tumors, moreover, generated spheroid in serum-free medium.These findings could provide foundation for the follow-up experiments. Key words: AC 133; Epithelial cell adhesion molecule; Colorectal cancer stem cells

About this research paper

What this paper is about

Objective To isolate colorectal cancer stem cells from human fresh carcinoma samples obtained at surgical operation and to study their biological characteristics.Then to provide foundation for the follow-up experiments. Methods Colorectal cancer tissues obtained from surgically resected specimens of colorectal cancer patients were fully chopped, trypsinized, and filtered to prepare single cell suspensions.The cells were cultured in serum-free DMEM/F12 medium, with LIF, EGF, bFGF and 2% fetal bovine serum weekly.The stem cell-markers AC133 and EpCAM on the isolated cells were detected by using flow cytometry.The tumorigenic potent of the isolated cells was evaluated via the transplantation into Balb/C nude mice.All the variables were tested with T-test.P<0.05 was considered to be statistically significant. Results AC133+ EpCAM+ colorectal cancer stem cells were isolated and purified from the human primary colorectal carcinoma.The percentage of AC133+ EpCAM+ colorectal cancer stem cells in primary colorectal cancer was 1.5%~35%(mean 4.8%). There were colon cancer stem cells in colon cancer by limited dilution assay.The percentage was 2.18±0.15%.The suspension spheres were generated by the isolated AC133+ EpCAM+ Co-CSCs in serum-free medium.Their differentiation were induced in medium containing 10% FBS.AC133+ EpCAM+ CCSCs were implanted into Balb/C nude mice, and observed stronger capacity of tumor initiation.The percentage of AC133+ EpCAM+ cells in xenografts was 4.9%~40.2%(mean 17.2%). Human CRC xenografts established in Balb/C nude mice grew as differentiated carcinomas, which formed gland-like structures and scored positive for expression of colon-specific differentiation markers, such as cytokeratin-20(CK20), and neutral epithelial mucins. Conclusions There are colon cancer stem cells in human colorectal carcinoma.These cells are characterized by AC133+ EpCAM+ surface marker, which possess apparent feature of stem cells and stronger capacity of initiating tumors, moreover, generated spheroid in serum-free medium.These findings could provide foundation for the follow-up experiments. Key words: AC 133; Epithelial cell adhesion molecule; Colorectal cancer stem cells

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To isolate colorectal cancer stem cells from human fresh carcinoma samples obtained at surgical operation and to study their biological characteristics.Then to provide foundation for the follow-up experiments. Methods Colorectal cancer tissues obtained from surgically resected specimens of colorectal cancer patients were fully chopped, trypsinized, and filtered to prepare single cell suspensions.The cells were cultured in serum-free DMEM/F12 medium, with LIF, EGF, bFGF and 2% fetal bovine serum weekly.The stem cell-markers AC133 and EpCAM on the isolated cells were detected by using flow cytometry.The tumorigenic potent of the isolated cells was evaluated via the transplantation into Balb/C nude mice.All the variables were tested with T-test.P<0.05 was considered to be statistically significant. Results AC133+ EpCAM+ colorectal cancer stem cells were isolated and purified from the human primary colorectal carcinoma.The percentage of AC133+ EpCAM+ colorectal cancer stem cells in primary colorectal cancer was 1.5%~35%(mean 4.8%). There were colon cancer stem cells in colon cancer by limited dilution assay.The percentage was 2.18±0.15%.The suspension spheres were generated by the isolated AC133+ EpCAM+ Co-CSCs in serum-free medium.Their differentiation were induced in medium containing 10% FBS.AC133+ EpCAM+ CCSCs were implanted into Balb/C nude mice, and observed stronger capacity of tumor initiation.The percentage of AC133+ EpCAM+ cells in xenografts was 4.9%~40.2%(mean 17.2%). Human CRC xenografts established in Balb/C nude mice grew as differentiated carcinomas, which formed gland-like structures and scored positive for expression of colon-specific differentiation markers, such as cytokeratin-20(CK20), and neutral epithelial mucins. Conclusions There are colon cancer stem cells in human colorectal carcinoma.These cells are characterized by AC133+ EpCAM+ surface marker, which possess apparent feature of stem cells and stronger capacity of initiating tumors, moreover, generated spheroid in serum-free medium.These findings could provide foundation for the follow-up experiments. Key words: AC 133; Epithelial cell adhesion molecule; Colorectal cancer stem cells

Key concepts: Epithelial cell adhesion molecule, Colorectal cancer, Cancer stem cell, Trypsinization, Stem cell, Cancer, Cancer research, Transplantation

Related papers

Back to paper searchBrowse research topicsOriginal source
The study of combining AC133 antigen and E-cadherin in the identifying metastatic colorectal cancer stem cells — Research Paper | ScholarLens